Still at least 2 yrs away from completing this new trial with the agreeable parameters suggested by FDA.
can't see much more upside to sp in short term unless more deals like the China one are announced.
Ann: Overview of ProstACT Phase III Study - Investor supplement, page-12
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.00 |
Change
0.040(0.18%) |
Mkt cap ! $7.349B | |||
| Open | High | Low | Value | Volume |
| $22.26 | $22.38 | $21.98 | $3.998M | 180.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 170 | $21.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.02 | 215 | 3 |
View Market Depth
| Last trade - 10.16am 21/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |